Buscopan Dosing for Renal Colic
Buscopan (hyoscine butylbromide) is NOT recommended for renal colic, as it provides no benefit over placebo for pain relief in this condition.
Evidence Against Buscopan Use
The most recent high-quality evidence definitively shows that continuous IV butylscopolamine (100 mg/24 hours) is non-inferior to placebo in patients with renal colic 1. This 2021 randomized controlled trial of 128 patients found no difference in opioid rescue medication requirements or pain scores between butylscopolamine and placebo groups. The study concluded there is no role for continuous butylscopolamine IV in the treatment of renal colic 1.
Recommended Treatment Instead
The evidence-based first-line treatment for renal colic is NSAIDs, specifically diclofenac 75 mg intramuscularly 2. This recommendation carries a Grade A evidence rating with level 1- evidence 2.
Treatment Algorithm:
- First-line: Diclofenac 75 mg IM to achieve pain relief within 30 minutes 2
- Alternative: If NSAIDs are contraindicated (allergy to NSAIDs or salicylates), use an opioid (such as morphine) combined with an antiemetic like cyclizine 2
- Route: Intramuscular injection is preferred; oral and rectal routes are unreliable in acute renal colic 2
- Follow-up: Assess response at 1 hour; if inadequate pain relief, arrange immediate hospital admission 2
Why Buscopan Doesn't Work for Renal Colic
While hyoscine butylbromide is an effective antispasmodic for gastrointestinal cramping through its anticholinergic effects on smooth muscle 3, 4, 5, renal colic pain is primarily caused by ureteral distension and inflammation from stone obstruction—not smooth muscle spasm. NSAIDs work by reducing inflammation and lowering pressure within the urinary collecting system 6, directly addressing the pathophysiology of renal colic.
Historical Context
Older studies from 1998 showed that even combination products (buscopan compositum containing hyoscine butylbromide 20 mg plus dipyrone 2.5 g) were inferior to NSAIDs, with 62% of patients experiencing pain relapse within 24 hours requiring rescue medication 7.